SuperworthPharmaCyte Biotech shares outstanding PMCB
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jul 31, 2026
- 10.7M
- On a year earlier
- +58.0%
- more shares
PharmaCyte Biotech had 10.7M diluted shares outstanding on average in Q1 FY27, the quarter to Jul 31, 2026.
That is 58.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 10.7M | +57% |
| FY2025 | 6.8M | −18% |
| FY2024 | 8.3M | −53% |
| FY2023 | 17.7M | −18% |
| FY2022 | 21.7M | +1271% |
| FY2021 | 1.6M | +56% |
| FY2020 | 1M | +37% |
| FY2019 | 741.9K | +15% |
| FY2018 | 645.8K | +13% |
| FY2017 | 571.6K | +15% |
| FY2016 | 496.8K | +9% |
| FY2015 | 457.8K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q1 FY27 | 10.7M | +58% | |
| Q4 FY26 | 10.7M | +57% | |
| Q3 FY26 | 9.3M | +33% | |
| Q2 FY26 | 6.8M | −11% | |
| Q1 FY26 | 6.8M | −14% | |
| Q4 FY25 | 6.8M | −18% | |
| Q3 FY25 | 7M | −19% | |
| Q2 FY25 | 7.6M | −13% | |
| Q1 FY25 | 7.9M | −38% | |
| Q4 FY24 | 8.3M | −53% | |
| Q3 FY24 | 8.6M | −55% | |
| Q2 FY24 | 8.8M | −57% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on PharmaCyte Biotech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.